Navigation Links
3 strikes, you're out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause

'They've gotten the science wrong. They've gotten the law wrong. Why should

we trust them to get cures right?'

ST. LOUIS, Sept. 5 /PRNewswire-USNewswire/ -- Missouri Coalition for Lifesaving Cures responded today as opponents of stem cell cures refiled their measure yet again, the third time in less than 2 weeks.

Said Donn Rubin, Chair of Missouri Coalition for Lifesaving Cures, "In their zeal to repeal stem cell research and criminalize doctors who pursue desperately needed cures, opponents of stem cell research have trampled both basic science and basic law. First their deceptive and far-reaching initiative would have excluded Missourians with common chromosomal abnormalities like Downs, Klinefelter and Turner syndromes from their definition of 'human.' Then their 'improved' initiative would have made their supporters' e-mail addresses part of the public record, opening them up to spammers and scammers. They simply can't get their act together. We shouldn't trust anything they put on the ballot."

Added Rubin, "Whether it's little errors or big ones, this initiative's supporters can't get anything right. But no matter how many times they rewrite and refile their initiative, their intent is the same: to repeal the stem cell measure passed by voters less than nine months ago."

Thanks to Missouri's passage of the Stem Cell Amendment last year, Missouri's constitution now guarantees equal access to stem cell research, treatment and cures allowed under federal law and available to other Americans. It also makes any attempt to clone a human being a felony crime, punishable by up to 15 years in prison and a $250,000 fine. The proposed initiative's plan to redefine stem cell research as "cloning" is really a disguised attempt to repeal the stem cell guarantees established by voters last year.

Missouri Coalition for Lifesaving Cures promotes cures for diseases such as Parkinson's and diabetes in Missouri. It is a grassroots group which includes more than 100 leading patient and medical organizations and more than 60,000 Missouri citizens.

Paid for by Missouri Coalition for Lifesaving Cures, Lindsay Holwick, Treasurer


Connie Farrow

(314) 808-1158

SOURCE Missouri Coalition for Lifesaving Cures
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Whats in a name? Quite a bit, when youre competing in biotech
2. Amendment on cloning ban rejected; vote on bill set for Wednesday
3. Detect Single Nucleotide Sequence Changes with Mx4000 Molecular Beacon Allelic Discrimination Kits
4. New Temperature Cycler Features Interchangeable Blocks
5. Mammalian Expression Vectors with Interchangeable Selectable Markers
6. The measurement of DNA condensation and mitochondrial changes during apoptosis and necrosis in cell based assays
7. Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation
8. Milwaukee takes another step in electronic patient data exchange
9. Changes to U.S. patent law must nurture our culture of innovation
10. Visions, Part II: Preizler sees IT leading incremental health system change
11. Why IT change management is more important than ever
Post Your Comments:
(Date:11/25/2015)... India , November 26, 2015 ... The Global Biobanking Market 2016 - 2020 report ... by maintaining integrity and quality in long-term samples, ... enabling long-term cost-effectiveness. Automation minimizes manual errors such ... the technical efficiency. Further, it plays a vital ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... San Francisco, CA (PRWEB) , ... November 25, ... ... leading microbial genomics company uBiome, were featured on AngelList early in their initial ... by launching an AngelList syndicate for individuals looking to make early stage investments ...
(Date:11/24/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended September 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of iCo ... value enriching for this clinical program, but also ...
Breaking Biology Technology:
(Date:10/27/2015)... In the present market scenario, security is ... industry verticals such as banking, healthcare, defense, electronic gadgets, ... for secure & simplified access control and growing rate ... of bank accounts, misuse of users, , and so ... laptops, and smartphones are expected to provide potential opportunities ...
(Date:10/27/2015)... Synaptics Inc. (NASDAQ: SYNA ), the leader ... adopted the Synaptics ® ClearPad ® Series ... newest flagship smartphones, the Nexus 5X by LG and ... --> --> Synaptics works closely with ... in the joint development of next generation technologies. Together, ...
(Date:10/26/2015)... and LAS VEGAS , Oct. ... Labs , an innovator in modern authentication and a ... announced the launch of its latest version of the ... enabling organizations to use standards-based authentication that supports existing ... S3 Authentication Suite is ideal for organizations deploying customer-facing ...
Breaking Biology News(10 mins):